Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Pre-Exercise Administration: Many users prefer to administer AOD-9604 30-60 minutes before morning cardiovascular exercise or fasted training sessions
Semaglutide and Tirzepatide are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
All products are supplied in powder (lyophilized) form and must be reconstituted with an appropriate diluent for research use only
Typical Duration of Therapy The duration of BPC-157 therapy varies based on the conditions severity: Acute injuries or mild inflammation: 24 weeks Moderate injuries or post-surgical recovery: 48 weeks Chronic or systemic conditions: 812 weeks or longer For best outcomes, BPC-157 may be combined with TB-500, Thymosin Beta-4, or KPV peptides, along with targeted nutrition and physiologic optimization
